Constitutively Activating EPOR
Document Type
Poster Presentation
Publication Date
4-17-2026
Keywords
fsc2026
Abstract
Abstract: Erythropoiesis, the process of making red blood cells, depends on signals from erythropoietin (EPO). In the lab, HUDEP‑2 cells are widely used to study human red blood cell development, but they require expensive EPO to survive and mature. This project proposes two strategies to make these cells grow without added EPO by creating “always‑on” versions of the EPO receptor (EPOR) or its signaling partner JAK2. One approach would introduce mutated genes using plasmids to artificially boost signaling. The second approach would use CRISPR/Cas9 to place activating mutations directly into the cell’s own DNA, allowing the receptor to function without EPO. If successful, this work would create a more affordable and accessible cell model for studying conditions like polycythemia, where the body produces too many red blood cells.
Publication Information
Anson, Erin, "Constitutively Activating EPOR" (2026). Fisher Showcase 2026. Paper 69.
https://fisherpub.sjf.edu/fsc2026/69
Please note that the Publication Information provides general citation information and may not be appropriate for your discipline. To receive help in creating a citation based on your discipline, please visit https://libguides.sjf.edu/citations.
Comments
Poster presented at the 2026 Fisher Showcase, St. John Fisher University, April 17, 2026.